Skip to main content
Equibles
QURE logo

QURE · uniQure N.V. · Metrics

Track QURE — free

Use QURE with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research QURE.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$22.72 +0.52 (+2.32%)
Rebalance outlook locked
Market Cap
$1.40B
Shares
63.07M
Volume · Oct 20 1.3M Avg daily vol (3M) 2.04M

QURE metrics

85 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$22.20
Market cap
$1.40B

Price action

20 metrics
Price change (1W)
+1.6%
Price change (30D)
-49.9%
Price change (3M)
-44.1%
Price change (6M)
+23.1%
Price change (YTD)
-7.2%
Price change (1Y)
-61.7%
Trailing year
Price change (5Y)
-22.2%
52-week high
$70.59
52-week low
$9.03
Change from 52-week high
-68.6%
Change from 52-week low
+145.8%
Annualized volatility
143.2%
Annualized volatility (3M)
89.3%
Beta
0.4
RSI (14D)
24.8
Price vs SMA 50
-42.8%
Price vs SMA 200
-25.1%
Avg volume (3M)
2.04M
Relative volume
0.7
Average dollar volume
$68.94M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
63.07M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
73.1×
reciprocal yield 1.4%
EV / EBITDA
—
EV / EBIT
—
P / sales
73.6×
reciprocal yield 1.4%
P / book
4.2
reciprocal yield 23.6%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-18.4%

Historical valuation

8 metrics
P / E historical average (3Y)
3.2×
reciprocal yield 30.8%
P / E historical average (5Y)
3.2×
reciprocal yield 30.8%
EV / revenue historical average (3Y)
23.1×
reciprocal yield 4.3%
EV / revenue historical average (5Y)
16.8×
reciprocal yield 5.9%
EV / EBIT historical average (3Y)
2.4×
reciprocal yield 42.0%
EV / EBIT historical average (5Y)
2.4×
reciprocal yield 42.0%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-29

Profitability

9 metrics
Gross margin
92.5%
Operating margin
-1,071.5%
Trailing 12 months
Net margin
-1,350.7%
Gross profit (TTM)
$17.27M
Operating profit (TTM)
−$200.08M
Net income (TTM)
−$252.21M
Trailing 12 months
Diluted EPS (TTM)
$-4.02
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$0.30
Gross profit per diluted share (TTM)
$0.27
Operating profit per diluted share (TTM)
$-3.19
EBITDA per diluted share (TTM)
$-2.96
Net income per diluted share (TTM)
$-4.04
Operating cash flow per diluted share (TTM)
$-2.54
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
$2.11
Stock compensation per diluted share (TTM)
$0.29
Book value per share
$4.67

Growth

11 metrics
Revenue growth YoY
+11.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$18.67M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+20.9%
Year over year · more shares
Revenue CAGR (3Y)
-46.7%
Revenue CAGR (5Y)
-15.6%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-77.8%
Return on assets
-25.6%
Debt / equity
0.4
Current ratio
10.0
EBITDA (TTM)
−$185.61M
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
-3.4
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$8.32M
Latest balance sheet
Cash & equivalents
$413.03M
Total assets
$985.10M
Total debt
$71.92M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$160.79M
Capital expenditures (TTM)
$665,000
R&D (TTM)
$132.29M
SG&A (TTM)
$78.48M
Stock compensation (TTM)
$18.29M
R&D / revenue
708.5%
Stock compensation / revenue
98.0%

Ownership (13F)

9 metrics
13F filers
259
13F filer change QoQ
+36
Institutional ownership
122.5%
Conviction holders (share of 13F filers)
2.8%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+13.3%
Holder tenure
10.9
Price vs estimated holder cost
+98.9%

Ownership (registered funds)

1 metrics
Index-fund ownership
1.5%

Short interest

3 metrics
Short interest
13.8%
Latest settlement · 1.9 days to cover
Days to cover
1.9d
Short-squeeze score
51 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1590560 CUSIP N90064101 13F (30d) 21 filings 21 filers Visit website Investor relations